Stacey B. Foti, Ph.D.
Affiliations: | 2008 | Neurobiology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Neuroscience Biology, Virology BiologyGoogle:
"Stacey Foti"Mean distance: 42746.4
Parents
Sign in to add mentor| Thomas McCown | grad student | 2008 | UNC Chapel Hill | |
| (Novel AAV-mediated therapeutic strategies for epilepsy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Goodrich LR, Phillips JN, McIlwraith CW, et al. (2013) Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis. Molecular Therapy. Nucleic Acids. 2: e70 |
| Gray SJ, Foti SB, Schwartz JW, et al. (2011) Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Human Gene Therapy. 22: 1143-53 |
| Koh MT, Haberman RP, Foti S, et al. (2010) Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1016-25 |
| Foti SB, Samulski RJ, McCown TJ. (2009) Delivering multiple gene products in the brain from a single adeno-associated virus vector. Gene Therapy. 16: 1314-9 |
| Foti SB, Russek SJ, Brooks-Kayal AR, et al. (2009) Viral vector gene therapy for epilepsy Neuromethods. 40: 235-250 |
| Foti S, Haberman RP, Samulski RJ, et al. (2007) Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo. Gene Therapy. 14: 1534-6 |